atrovent 250 udvs 250 micrograms/ 1ml nebuliser solution
boehringer ingelheim international gmbh - ipratropium bromide - nebuliser solution - 250 microgram(s)/millilitre - anticholinergics; ipratropium bromide
atrovent 500 udvs, 500 micrograms/ 2ml nebuliser solution
boehringer ingelheim international gmbh - ipratropium bromide - nebuliser solution - 500 micrograms/2 ml microgram(s) - anticholinergics; ipratropium bromide
aerovent
boehringer ingelheim israel ltd. - ipratropium bromide - respirator solution - ipratropium bromide 0.25 mg/ml - ipratropium bromide - ipratropium bromide - for the relief of symptoms of reversible bronchospasm associated with asthma, chronic bronchitis and emphysema . aerovent respirator solution is of particular benefit in relieving acute bronchospasm when used concomitantly with inhaled beta agonists.
atrovent
boehringer ingelheim israel ltd. - ipratropium bromide - inhaler - ipratropium bromide 0.02 mg - ipratropium bromide - ipratropium bromide - for the relief of symptoms of reversible bronchospasm associated with asthma, chronic bronchitis and emphysema.
atrovent inhaler cfc-free
boehringer ingelheim limited - ipratropium bromide - pressurised inhalation soln - 20 mcg/dose - ipratropium bromide
atrovent n metered dose inhaler 20 mcgpuff
boehringer ingelheim singapore pte. ltd. - ipratropium bromide - aerosol, spray - 20 mcg/dose - ipratropium bromide 20 mcg/dose
atrovent solution 0.025%
boehringer ingelheim singapore pte. ltd. - ipratropium bromide - solution - 0.25 mg/ml - ipratropium bromide 0.25 mg/ml
atrovent 500 udvs, 500 mcg/2ml nebuliser solution
boehringer ingelheim limited - ipratropium bromide - nebuliser solution - ipratropium bromide 500 µg - drugs for obstructive airway diseases
bretaris genuair
covis pharma europe b.v. - aclidinium bromide - pulmonary disease, chronic obstructive - drugs for obstructive airway diseases, - bretaris genuair is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd).
eklira genuair
covis pharma europe b.v. - aclidinium bromide - pulmonary disease, chronic obstructive - drugs for obstructive airway diseases, - eklira genuair is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd).